Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CLSK vs GSK✓SelectedUSD · GSKCLSK vs GSK performance historyLatest closeAs of+0.98%11/18
Stock and ETF performance explorer

CLSK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-82.2%
GSK return
+101.2%
Excess return
-183.4%
Maximum drawdown
-98.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.0%-1.3%+2.3%+0.9%
7D-10.1%-3.1%-7.0%-10.3%
30D-26.6%-0.9%-25.7%-26.5%
3M-47.1%-4.2%-42.9%-47.0%
6M-53.8%-1.6%-52.2%-53.8%
YTD-38.6%+2.6%-41.2%-38.6%
1Y-42.6%+6.2%-48.8%-42.6%
3Y+57.6%+55.0%+2.6%+54.7%
5Y-63.8%+42.8%-106.6%-65.0%
10Y-82.2%+102.1%-184.3%-72.8%
All-82.2%+101.2%-183.4%-72.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling